Life Science Tools Market Analysis Report By Technology, By Product, By End-use, By Region And Segment Forecasts From 2021 To 2028

Synopsis

With reference to the report published, the global life science tools market was prized by USD 92.2 billion in 2020. It is estimated to witness an 11.9% CAGR from 2021 to 2028.

Drivers

The expected revenue enlargement is credited to the speedy technical developments, accepted by the manufacturing companies of life science tools. The likely enlargement in revenue is credited to the speedy technical progressions adopted by the life science tools manufacturing firms in chromatography methods, NMR, sequencing technologies, mass spectrometry, and additional products. The global substantial growth in Covid-19 cases increases the requirement for life science tools, intended for speedy diagnosis.

Since humankind is busy restricting the increase of Covid-19, robotic & automation machinery performs a significant function in speeding up the physical as well as unnecessary everyday jobs, in pharmaceutical laboratories and companies.

To conquer the Covid-19 virulent disease, medicine developers are constantly operational on the improvement of the vaccines as well as additional alternatives of the therapy. The robot manufacturing companies are extremely operational in this area and are presenting a mechanized resolution to medicine developers, to speed up the laborious steps of the medicine manufacturing procedures.

The Hamilton Company presented two automatic assembly-ready workstations, the Prep STARlet, and MagEx STARlet, to help healthcare researchers and the experts, occupied in the investigation of coronavirus, in March 2020. These two automatic workstations are sourced on the Micro lab STARlet fluid treatment workstation, made by Hamilton Company. Consecutively, it makes easy, speedy, extremely productive research and analytical based test of SARS-CoV-2.

Product Insight

The cell culture systems and 3D cell culture sector held the principal 17.9% revenue share and led the life science tools market, in 2020. On the other hand, the nucleic acid microarray & cloning and genome engineering subdivision are estimated to record, well-paid development ratios.

Due to the greater use in Covid-19 analysis, the PCR & qPCR sector observed sizeable enlargement, from 2019 to 2020. COVID-19 discovery examinations are sourced on RT-PCR tools for the quantification of RNA, in the taster of coronavirus-influenced patients.

Extensive acceptance of PCR through government organizations, like the public health laboratories, hospitals, commercial laboratories, and CDC has done considerable assistance to the revenue, created by this product sector, in the market for life science tools.

Technology Insight

The cell biology technology sector held the biggest 33.9% revenue share and led the life science tools market, in 2020. The sector is strongly tracked by genomics technology. The conventional genome editing technologies contain a restricted capability of keeping swiftness with the speedily advancing genome alteration period, due to the reality that these technologies are physical, prolonged, and incompetent.

The proteomics sector is anticipated to increase by a major CAGR, because proteome analysis is able to offer a total representation of the useful and structural data of the cell as well as their reaction method, in contrast to the medicines and additional unknown features.

End-Use Insight

In 2020, the health care section held the biggest, 33.7% revenue share, and led the life science tools market. This section consists of physician offices, diagnostic laboratories, hospitals, community centers, and clinics.

The rising acceptance of proteomic and genomic workflows in hospitals, headed for making a diagnosis and take care of a number of medical irregularities, is estimated to impel the market for life science tools. Besides, hard work done by the clinics and hospitals, to increase their opening for genomics study is, moreover, estimated to increase the expansion of the market.

Additionally, due to the increasing requirement for the analytical tests for Covid-19, a pandemic virus confirmed by the WHO, U.S. FDA has specified an emergency endorsement to a diagnostic, beneath which, trial producer Roche, acknowledged an Emergency Use Authorization (EUA). Such types of programs are anticipated to push the acceptance of life science tools, in the diagnostics segment.

Regional Insight

Due to the features like the nicely synchronized framework for handling and endorsement of the genomic experiments, a trustworthy informatics system, and the regional existence of the most important companies like Thermo Fisher Scientific, North America held the major 46.1% share and dominated the global life science tools market, in 2020.

Moreover, an increase in the figure of genomic actions for scientific as well as educational purposes in the U.S. is anticipated to power the market in North America, right through the forecast period.

The market in the Asia Pacific is in a position to observe the highest development, during the forecast period, due to the rising infiltration of foremost companies in budding Asian nations and funds for the invention of sophisticated analytical techniques.

Since, the province offers trained specialists on greatly lesser charges, in contrast to the industrialized nations of Europe and North America, Asia Pacific is a profitable destination for subcontracting pharmacological R&D projects. On account of the beneficial openings in a number of Asian nations, global CROs have extended their existence in the Asia Pacific.

Companies

Globally, Thermo Fisher Scientific is the single major provider of an extensive variety of inventive resolutions. The company’s goods are utilized by healthcare experts and researchers, all over the world. Its product range comprises thermal cyclers, flow cytometry instruments, sequencing solutions, nucleic acid purification solutions, and additional laboratory equipment.

Some of the companies for life science tools market are:

    • Zeiss International
    • Bruker
    • Shimadzu Corporation
    • QIAGEN
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Becton, Dickinson and Company
    • Oxford Instruments plc
    • Hitachi, Ltd.
    • Merck KGaA
    • Thermo Fisher Scientific, Inc
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Agilent Technologies

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2028. For the purpose of this study, Million Insights has segmented the global life science tools market report on the basis of technology, product, end-use, and region:

Life Science Tools Technology Outlook (Revenue, USD Million, 2017 - 2028)
    • Genomic Technology
    • Proteomics Technology
    • Cell Biology Technology
    • Other Analytical & Sample Preparation Technology
    • Lab Supplies & Technologies

Life Science Tools Product Outlook (Revenue, USD Million, 2017 - 2028)
    • Cell Culture Systems & 3D Cell Culture
        • Instrument
        • Consumables
        • Cell & Tissue Culture Services
    • Liquid Chromatography
        • Instrument
        • Consumables
        • Services
    • Mass Spectrometry
        • Instrument
        • Consumables
        • Services
    • Flow Cytometry
        • Instrument
        • Consumables
        • Services
    • Cloning & Genome Engineering
        • Kits, Reagents, and Consumables
        • Services
    • Microscopy & Electron Microscopy
        • Instrument
        • Consumables
        • Services
    • Next Generation Sequencing
        • Instrument
        • Consumables
        • Services
    • PCR & qPCR
        • Instrument
        • Consumables
        • Services
    • Nucleic Acid Preparation
        • Instrument
        • Consumables
        • Services
    • Nucleic Acid Microarray
        • Instrument
        • Consumables
        • Services
    • Sanger Sequencing
        • Instrument
        • Consumables
        • Services
    • Transfection Devices & Gene Delivery Technologies
        • Equipment
        • Reagents
    • NMR
        • Instrument
        • Consumables
        • Services
    • Other Separation Technologies
        • Instrument
        • Consumables
        • Services
    • Other Products & Services
        • Antibody Assays
        • General Supplies
        • Others
                • Instrument
                • Consumables
                • Services

• End-use Outlook (Revenue, USD Million, 2017 - 2028)
    • Government & Academic
    • Biopharmaceutical Company
    • Health Care
    • Industry
    • Others

• Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
    • The Asia Pacific
        • Japan
        • China
        • India
    • Latin America
        • Brazil
        • Mexico
    • MEA
        • South Africa
        • Saudi Arabia